Microbot Medical Announces Agreement With Brigham And Women's Hospital To Conduct Pivotal Human Clinical Trial For LIBERTY Endovascular Robotic Surgical System As Part Of IDE Application
Portfolio Pulse from Benzinga Newsdesk
Microbot Medical has announced an agreement with Brigham and Women's Hospital to conduct a pivotal human clinical trial for its LIBERTY Endovascular Robotic Surgical System. The trial is part of an IDE application, and following FDA approval, site initiation has begun with multiple robotic systems already received to support the trial.
June 20, 2024 | 12:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Microbot Medical has entered into an agreement with Brigham and Women's Hospital to conduct a pivotal clinical trial for its LIBERTY Endovascular Robotic Surgical System. The trial is part of an IDE application, and site initiation has begun following FDA approval.
The agreement with a prestigious hospital and the commencement of a pivotal clinical trial following FDA approval are significant milestones for Microbot Medical. This development is likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100